Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Canadian Sec - Delayed Quote CAD

Predictmedix AI Inc. (PMED.CN)

Compare
0.0250
-0.0050
(-16.67%)
At close: April 4 at 3:57:19 PM EDT
Loading Chart for PMED.CN
  • Previous Close 0.0300
  • Open 0.0350
  • Bid 0.0200 x --
  • Ask 0.0350 x --
  • Day's Range 0.0250 - 0.0350
  • 52 Week Range 0.0050 - 0.0550
  • Volume 77,000
  • Avg. Volume 316,778
  • Market Cap (intraday) 4.157M
  • Beta (5Y Monthly) 2.02
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date May 28, 2025 - Jun 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Predictmedix AI Inc., an artificial intelligence (AI) company, develops AI powered technologies for general workplace health and safety, and health care industry. It operates in two segments, Workplace Health and Safety, and Healthcare. The company offers disease symptom screening solutions to identify persons who are more likely to test positive for infectious diseases and to undergo a definitive test, such as a rapid COVID test. It also develops impairment detection screening scanners and mental health screening stations; and Mobile Wellbeing, a telemedicine remote patient monitoring platform. The company was formerly known as Predictmedix Inc. and changed its name to Predictmedix AI Inc. in July 2023. The company is headquartered in Toronto, Canada.

www.Predictmedix.com

--

Full Time Employees

January 31

Fiscal Year Ends

Recent News: PMED.CN

View More

Performance Overview: PMED.CN

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

PMED.CN
66.67%
S&P/TSX Composite index (^GSPTSE)
5.80%

1-Year Return

PMED.CN
37.50%
S&P/TSX Composite index (^GSPTSE)
5.18%

3-Year Return

PMED.CN
84.37%
S&P/TSX Composite index (^GSPTSE)
5.02%

5-Year Return

PMED.CN
82.76%
S&P/TSX Composite index (^GSPTSE)
79.26%

Compare To: PMED.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PMED.CN

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    4.16M

  • Enterprise Value

    4.12M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    719.51

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    500.62

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -146.31%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -1.14M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    413.68k

Research Analysis: PMED.CN

View More

Company Insights: PMED.CN

Research Reports: PMED.CN

View More

People Also Watch